Q32 Bio Inc.
QTTB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24,236 | $18,174 | $20,126 | $41,960 |
| - Cash | $49,039 | $54,832 | $65,483 | $77,965 |
| + Debt | $11,353 | $18,697 | $18,799 | $18,901 |
| Enterprise Value | -$13,450 | -$17,961 | -$26,558 | -$17,104 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$91 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,089 | -$9,098 | -$10,612 | $6,709 |
| % Margin | – | – | – | – |
| Net Income | -$7,389 | -$9,489 | -$11,031 | -$14,189 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.78 | -0.9 | -1.16 |
| % Growth | 23.1% | 13.3% | 22.4% | – |
| Operating Cash Flow | -$4,230 | -$10,651 | -$12,482 | -$11,428 |
| Capital Expenditures | $0 | $0 | $0 | -$2 |
| Free Cash Flow | -$4,230 | -$10,651 | -$12,482 | -$11,430 |